Tvardi Therapeutics Statistics
NASDAQ: TVRDHealth CareBiotechnology: Pharmaceutical PreparationsUSD
1.04-0.04 (-3.67%)
Market open · Delayed 15 min · as of Oct 9, 10:47 AM ET
Tvardi Therapeutics by the numbers
Tvardi Therapeutics has a market capitalization of $13.9 million based on 13.34M shares outstanding. With trailing EPS of $-2.84, Tvardi Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 38.1% below its 50-day average and 65.6% below its 200-day average.
Average daily trading volume is 424.45K shares, or about $441,432 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
TVRD valuation vs. peer median
| Metric | TVRD | Peer median | Difference |
|---|---|---|---|
| Market cap | $13.87M | $14.99M | -7% |
| Avg. volume | 424.45K | 536.25K | -21% |
Peer median across 8 companies: BFRI, AEON, KTTA, HIND, DARE, LPCN, ACTU, KPTI.
Valuation
- Market cap
- $13.87M
- EPS (TTM)
- $-2.84
- Shares outstanding
- 13.34M
Price and trading
- Previous close
- 1.08
- Open
- 1.09
- Day range
- 1.04 – 1.09
- 52-week range
- 0.93 – 43.65
- 52-week change
- -97.29%
- Beta
- —
- Volume
- 71.95K
- Average volume
- 424.45K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 14, 2026
Additional statistics
- Market Cap
- 13.87M
- Forward Pe
- -0.46
- Eps
- -2.84
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 43.65
- Week52 Low
- 0.93
- Avg Volume
- 424.45K
- Shares Outstanding
- 13.34M
- Ma50
- 1.68
- Ma200
- 3.02
- Earnings Date
- Aug 14, 2026
- Pct From52w High
- -97.62%
- Pct From52w Low
- 11.83%